We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Study Confirms Value of Laparoscopy for Obesity

By HospiMedica staff writers
Posted on 23 Oct 2000
A study has shown that laparoscopic gastric bypass surgery is a safe and effective procedure for achieving significant weight loss in morbidly obese people, with a low rate of complications, a short hospital stay, and rapid recovery. More...
The study was published in the October issue of the Annals of Surgery.

The surgery, called laparoscopic Roux-en-Y gastric bypass, is a minimally invasive procedure, with surgeons making four or five small incisions rather than one large one to access the abdominal cavity. They then construct a small stomach pouch and bypass a small segment of intestines by constructing a Y-shaped limb of small bowel.

The study involved 275 patients, aged 17-68, who averaged over 300 pounds prior to surgery. Many had other medical problems such as diabetes, sleep apnea, and cardiopulmonary disease, and 63% had undergone prior abdominal surgery. Only 3.3% has major complications. Following surgery, excess weight loss at 24 and 30 months was 83% and 77%.

At one year follow-up, 95% of the patients reported significant improvement in their quality of life. Among patients with osteoarthritis, 47% said their condition was improved, and 41% said it was resolved. Among patients with hypertension, 70% said the condition was resolved following surgery. Diabetics has the most profound improvement, claiming an 83% cure rate.

The important outcomes relating to the goal of open bariatric surgery such as weight loss and improvement of comorbidities and quality of life appear to be equally favorable for minimally invasive gastric bypass, noted Philip Schauer, M.D., assistant professor of surgery and director of bariatric surgery at the University of Pittsburgh School of
Medicine (PA, USA). Long-term follow-up, however, will be necessary to confirm that the laparoscopic approach is equally enduring.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.